[
  {
    "ts": null,
    "headline": "Johnson & Johnson (NYSE:JNJ) Showcases Paradigm-Shifting Bladder Cancer Trials at AUA 2025",
    "summary": "Johnson & Johnson (NYSE:JNJ) recently announced upcoming presentations at the AUA Annual Meeting, showcasing promising developments in its oncology pipeline, particularly therapies TAR-200 and TAR-210, which could have impacted its stock by highlighting innovative advances. During the last quarter, J&J's share price moved up 5.92%, amid a broader market upswing driven by strong trading sessions like the Dow Jones' 1,000-point surge. The company’s efforts in enhancing its dividend by 4.8% and...",
    "url": "https://finnhub.io/api/news?id=0018d1723a52f82130f84b05b939aaf1996c371ce46095f7c195d4e1d7a80904",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745342895,
      "headline": "Johnson & Johnson (NYSE:JNJ) Showcases Paradigm-Shifting Bladder Cancer Trials at AUA 2025",
      "id": 134038787,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) recently announced upcoming presentations at the AUA Annual Meeting, showcasing promising developments in its oncology pipeline, particularly therapies TAR-200 and TAR-210, which could have impacted its stock by highlighting innovative advances. During the last quarter, J&J's share price moved up 5.92%, amid a broader market upswing driven by strong trading sessions like the Dow Jones' 1,000-point surge. The company’s efforts in enhancing its dividend by 4.8% and...",
      "url": "https://finnhub.io/api/news?id=0018d1723a52f82130f84b05b939aaf1996c371ce46095f7c195d4e1d7a80904"
    }
  },
  {
    "ts": null,
    "headline": "Roche invests $50 billion in US manufacturing, avoiding Trump tariffs",
    "summary": "Copyright © BusinessAMBE 2023Key takeawaysRoche is investing $50 billion in U.S. manufacturing over a five-year period.The company plans to create more than 12,000 new jobs through...",
    "url": "https://finnhub.io/api/news?id=9b1b6133068cc7aca077e3c896c37c36eefeaf855a1766c7d016dc8b896e12cd",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745330471,
      "headline": "Roche invests $50 billion in US manufacturing, avoiding Trump tariffs",
      "id": 134034969,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Copyright © BusinessAMBE 2023Key takeawaysRoche is investing $50 billion in U.S. manufacturing over a five-year period.The company plans to create more than 12,000 new jobs through...",
      "url": "https://finnhub.io/api/news?id=9b1b6133068cc7aca077e3c896c37c36eefeaf855a1766c7d016dc8b896e12cd"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.30",
    "summary": "The board of Johnson & Johnson ( NYSE:JNJ ) has announced that the dividend on 10th of June will be increased to $1.30...",
    "url": "https://finnhub.io/api/news?id=7b31f15e0e55b0c25839bf1c2e377213709783c47f6654735196d4bbe6a9e7f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745319511,
      "headline": "Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.30",
      "id": 134031923,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The board of Johnson & Johnson ( NYSE:JNJ ) has announced that the dividend on 10th of June will be increased to $1.30...",
      "url": "https://finnhub.io/api/news?id=7b31f15e0e55b0c25839bf1c2e377213709783c47f6654735196d4bbe6a9e7f4"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron to invest over $3 billion to boost US manufacturing",
    "summary": "Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially doubling its U.S. manufacturing capacity and...",
    "url": "https://finnhub.io/api/news?id=0c6b7cf154ef0753a757e1e605c12ca28fbc18694d4184cb7780f708eb9437ec",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745316000,
      "headline": "Regeneron to invest over $3 billion to boost US manufacturing",
      "id": 134033367,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially doubling its U.S. manufacturing capacity and...",
      "url": "https://finnhub.io/api/news?id=0c6b7cf154ef0753a757e1e605c12ca28fbc18694d4184cb7780f708eb9437ec"
    }
  },
  {
    "ts": null,
    "headline": "ORIC Pharmaceuticals: Multiple Data Releases In 2025 Make It A Must-Watch Biotech",
    "summary": "ORIC Pharmaceuticals: Multiple Data Releases In 2025 Make It A Must-Watch Biotech",
    "url": "https://finnhub.io/api/news?id=c8d176046425a174e0beeab5165bf0a5beaf43791e9fed135b6591aa21a29767",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745313337,
      "headline": "ORIC Pharmaceuticals: Multiple Data Releases In 2025 Make It A Must-Watch Biotech",
      "id": 134033180,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=c8d176046425a174e0beeab5165bf0a5beaf43791e9fed135b6591aa21a29767"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings?",
    "summary": "Johnson & Johnson has been treading water for the past six months, recording a small loss of 3.8% while holding steady at $157.30. However, the stock is beating the S&P 500’s 11% decline during that period.",
    "url": "https://finnhub.io/api/news?id=f9db8439c427ccc092d6c17c1e13f17e112765bd355e6083c2909d8bc3a9026a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745312612,
      "headline": "Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings?",
      "id": 134031924,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson has been treading water for the past six months, recording a small loss of 3.8% while holding steady at $157.30. However, the stock is beating the S&P 500’s 11% decline during that period.",
      "url": "https://finnhub.io/api/news?id=f9db8439c427ccc092d6c17c1e13f17e112765bd355e6083c2909d8bc3a9026a"
    }
  },
  {
    "ts": null,
    "headline": "Two Stocks To Consider During Market Unrest To Provide Income Stability",
    "summary": "Two Stocks To Consider During Market Unrest To Provide Income Stability",
    "url": "https://finnhub.io/api/news?id=be89f9b4f17e4cc3ec4b8899a6d14a3f35400eb1c84bb341614f1810976780b6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745307000,
      "headline": "Two Stocks To Consider During Market Unrest To Provide Income Stability",
      "id": 134031789,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=be89f9b4f17e4cc3ec4b8899a6d14a3f35400eb1c84bb341614f1810976780b6"
    }
  }
]